KLK6 and non-small cell lung carcinoma: KLK6 regulated the proliferation and apoptosis of non-small-cell lung cancer cells via cleavage and activation of PAR2, which in turn activated the ligand-dependent epidermal growth factor receptor (EGFR) pathway [31].